A Bioinformatician Turned Investor Seeks to Transform Drug Development with Technology

Francisco Gimenez, a member of the 8VC investment team, sits down with Neil to discuss how his background in data science and bioinformatics shapes his investment approach and the potential to transform drug development with technology.